Global Antibacterial Drugs Market – Industry Analysis and Forecast (2019-2026) –By Drug Class, Drug Mechanism, Route of Administration, Distribution Channel, and Region.

Global Antibacterial Drugs Market was valued at US$ 26.4 Bn in 2019 and is expected to reach US$ 34.2 Bn by 2026, at a CAGR of 3.29% during a forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region. To know about the Research Methodology:-Request Free Sample Report Growth in the old population, rising demand for efficient & affordable antibacterial drugs, and an increasing number of multi-drug resistant bacterial strains are some of the key factors that are driving the global antibacterial drugs market. The high prevalence of infectious diseases, increased research and development activities, product differentiation through various methods, and rise in government support are boosting the growth of the market. The growing number of product approval and subsequent launch of the products is the main factor expected to boost the growth of the market over the forecast period. Reduced time for action and fewer side effects are projected to offer a good opportunity for the growth of the antibacterial drugs market. However, the rise in drug-resistant species, the launch of generic drugs, and patent expiry are limiting the growth of the market. The retail pharmacies segment accounts for a major revenue share of the global antibacterial drugs market owing to providing advice about health issues, symptoms & medications responding to customer inquiries, recruiting, training & managing staff, and treating prescriptions & dispensing medication. Penicillin is a group of antibiotics, which contain penicillin G, penicillin V, procaine penicillin, and benzathine penicillin. Penicillin antibiotics are among the first medications to be in effect against many bacterial infections caused by staphylococci and streptococci. The cephalosporins are a class of β-lactam antibiotics, which are originally derived from the fungus Acremonium. Cephalosporin drugs are used to treat bacterial infections including ear & skin infections, pneumonia, kidney & bone infections, sexually transmitted infections such as gonorrhea, and strep throat & other throat infections. Cell wall biosynthesis inhibitors (CBIs) is one of the most effective mechanism of antibiotics and the most extensively used class of antibiotics. However, this mechanism of antibiotics is not received impunity from resistance development. North America is leading the global antibacterial drugs market in terms of revenue owing to the presence of significant market players in the region. Europe accounts for the second-largest revenue share in the global antibacterial drugs market, followed by Asia Pacific, South America, and the Middle East & Africa respectively. The Asia Pacific is estimated to register comparatively faster growth in terms of revenue during the forecast period owing to the increasing number of healthcare infrastructure and the growing prevalence of bacterial infections. Key players operating in the global antibacterial drugs market are Pfizer, Inc., Merck & Co., Inc. Johnson & Johnson, and GlaxoSmithKline plc. The report covers a comprehensive study of major market drivers, restraints, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.

The Scope of the Global Antibacterial Drugs Market: Inquire before buying

Global Antibacterial Drugs Market, by Drug Class:

• Penicillins • Cephalosporins • Quinolone • Aminoglycosides • Monobactams • Carbapenems • Macrolides • Other Drug Class

Global Antibacterial Drugs Market, by Drug Mechanism:

• Cell Wall Synthesis inhibitors • Protein Synthesis inhibitors • Nucleic Acid inhibitors • Folic Acid synthesis inhibitors • Mycolic Acid synthesis inhibitors

Global Antibacterial Drugs Market, by Route of Administration:

• Oral • Topical • Parenteral • Other Route of Administration

Global Antibacterial Drugs Market, by Distribution Channel:

• Hospital Pharmacies • Drug Stores & Retail Pharmacies • Online Sales

Global Antibacterial Drugs Market, by Region:

• North America • Europe • Asia-Pacific • South America • Middle East & Africa

Key Player Operating in the Global Antibacterial Drugs Market:

• Pfizer, Inc. • Merck & Co., Inc. • GlaxoSmithKline plc. • Novartis AG • Eli Lilly & Company • Johnson & Johnson • Sanofi • AstraZeneca plc. • Bayer AG • Abbott Laboratories • Daiichi Sankyo Company • Takeda Pharmaceutical Company Ltd • Bristol Myers Squibb Company • Allergen Plc.

Global Antibacterial Drugs Market

1. Preface 1.1. Research Objectives 1.2. Report Scope and Market Segmentation 2. Assumptions and Research Methodology 2.1. Abbreviations 3. Executive Summary 3.1. Global Antibacterial Drugs Market Size, by Market Value (US$ Bn) and Market 4. Market Overview 4.1. Introduction 4.2. Market Dynamics 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.3.7.Key Trends in Global Antibacterial Drugs Market 5. Global Antibacterial Drugs Market Analysis and Forecast 5.1. Global Antibacterial Drugs Market Size& Y-o-Y Growth Analysis 5.1.1. North America 5.1.2. Europe 5.1.3. Asia Pacific 5.1.4. Middle East & Africa 5.1.5. South America 6. Global Antibacterial Drugs Market Analysis and Forecast, By Drug Class 6.1. Introduction and Definition 6.2. Global Antibacterial Drugs Market Value Share Analysis, By Drug Class 6.3. Global Antibacterial Drugs Market Size (US$ Bn) Forecast, By Drug Class 6.4. Global Antibacterial Drugs Market Analysis, By Drug Class 6.5. Global Antibacterial Drugs Market Attractiveness Analysis, By Drug Class 6.6. Key Trends 6.6.1. Key Developments 7. Global Antibacterial Drugs Market Analysis and Forecast, By Drug Mechanism 7.1. Introduction and Definition 7.2. Global Antibacterial Drugs Market Value Share Analysis, By Drug Mechanism 7.3. Global Antibacterial Drugs Market Size (US$ Bn) Forecast, By Drug Mechanism 7.4. Global Antibacterial Drugs Market Analysis, By Drug Mechanism 7.5. Global Antibacterial Drugs Market Attractiveness Analysis, By Drug Mechanism 7.6. Key Trends 7.6.1. Key Developments 8. Global Antibacterial Drugs Market Analysis and Forecast, By Route of Administration 8.1. Introduction and Definition 8.2. Global Antibacterial Drugs Market Value Share Analysis, By Route of Administration 8.3. Global Antibacterial Drugs Market Size (US$ Bn) Forecast, By Route of Administration 8.4. Global Antibacterial Drugs Market Analysis, By Route of Administration 8.5. Global Antibacterial Drugs Market Attractiveness Analysis, By Route of Administration 8.6. Key Trends 8.6.1. Key Developments 9. Global Antibacterial Drugs Market Analysis and Forecast, By Distribution Channel 9.1. Introduction and Definition 9.2. Global Antibacterial Drugs Market Value Share Analysis, By Distribution Channel 9.3. Global Antibacterial Drugs Market Size (US$ Bn) Forecast, By Distribution Channel 9.4. Global Antibacterial Drugs Market Analysis, By Distribution Channel 9.5. Global Antibacterial Drugs Market Attractiveness Analysis, By Distribution Channel 9.6. Key Trends 9.6.1. Key Developments 10. Global Antibacterial Drugs Market Analysis, by Region 10.1. Global Antibacterial Drugs Market Value Share Analysis, by Region 10.2. Global Antibacterial Drugs Market Size (US$ Bn) Forecast, by Region 10.3. Global Antibacterial Drugs Market Attractiveness Analysis, by Region 10.4. Key Trends 10.4.1. Key Developments 11. North America Antibacterial Drugs Market Analysis 11.1. Key Findings 11.2. North America Antibacterial Drugs Market Overview 11.3. North America Antibacterial Drugs Market Value Share Analysis, By Drug Class 11.4. North America Antibacterial Drugs Market Forecast, By Drug Class 11.4.1. Penicillins 11.4.2. Cephalosporins 11.4.3. Quinolone 11.4.4. Aminoglycosides 11.4.5. Monobactams 11.4.6. Carbapenems 11.4.7. Macrolides 11.4.8. Other Drug Class 11.5. North America Antibacterial Drugs Market Value Share Analysis, By Drug Mechanism 11.6. North America Antibacterial Drugs Market Forecast, By Drug Mechanism 11.6.1. Cell Wall Synthesis inhibitors 11.6.2. Protein Synthesis inhibitors 11.6.3. Nucleic Acid inhibitors 11.6.4. Folic Acid synthesis inhibitors 11.6.5. Mycolic Acid synthesis inhibitors 11.7. North America Antibacterial Drugs Market Value Share Analysis, By Route of Administration 11.8. North America Antibacterial Drugs Market Forecast, By Route of Administration 11.8.1. Oral 11.8.2. Topical 11.8.3. Parenteral 11.8.4. Other Route of Administration 11.9. North America Antibacterial Drugs Market Value Share Analysis, By Distribution Channel 11.10. North America Antibacterial Drugs Market Forecast, By Distribution Channel 11.10.1. Hospital Pharmacies 11.10.2. Drug Stores & Retail Pharmacies 11.10.3. Online Sales 11.11. North America Antibacterial Drugs Market Value Share Analysis, by Country 11.12. North America Antibacterial Drugs Market Forecast, by Country 11.12.1. U.S. 11.12.2. Canada 11.13. North America Antibacterial Drugs Market Analysis, by Country 11.14. U.S. Antibacterial Drugs Market Forecast, By Drug Class 11.14.1. Penicillins 11.14.2. Cephalosporins 11.14.3. Quinolone 11.14.4. Aminoglycosides 11.14.5. Monobactams 11.14.6. Carbapenems 11.14.7. Macrolides 11.14.8. Other Drug Class 11.15. U.S. Antibacterial Drugs Market Forecast, By Drug Mechanism 11.15.1. Cell Wall Synthesis inhibitors 11.15.2. Protein Synthesis inhibitors 11.15.3. Nucleic Acid inhibitors 11.15.4. Folic Acid synthesis inhibitors 11.15.5. Mycolic Acid synthesis inhibitors 11.16. U.S. Antibacterial Drugs Market Forecast, By Route of Administration 11.16.1. Oral 11.16.2. Topical 11.16.3. Parenteral 11.16.4. Other Route of Administration 11.17. U.S. Antibacterial Drugs Market Forecast, By Distribution Channel 11.17.1. Hospital Pharmacies 11.17.2. Drug Stores & Retail Pharmacies 11.17.3. Online Sales 11.18. Canada Antibacterial Drugs Market Forecast, By Drug Class 11.18.1. Penicillins 11.18.2. Cephalosporins 11.18.3. Quinolone 11.18.4. Aminoglycosides 11.18.5. Monobactams 11.18.6. Carbapenems 11.18.7. Macrolides 11.18.8. Other Drug Class 11.19. Canada Antibacterial Drugs Market Forecast, By Drug Mechanism 11.19.1. Cell Wall Synthesis inhibitors 11.19.2. Protein Synthesis inhibitors 11.19.3. Nucleic Acid inhibitors 11.19.4. Folic Acid synthesis inhibitors 11.19.5. Mycolic Acid synthesis inhibitors 11.20. Canada Antibacterial Drugs Market Forecast, By Route of Administration 11.20.1. Oral 11.20.2. Topical 11.20.3. Parenteral 11.20.4. Other Route of Administration 11.21. Canada Antibacterial Drugs Market Forecast, By Distribution Channel 11.21.1. Hospital Pharmacies 11.21.2. Drug Stores & Retail Pharmacies 11.21.3. Online Sales 11.22. North America Antibacterial Drugs Market Attractiveness Analysis 11.22.1. By Drug Class 11.22.2. By Drug Mechanism 11.22.3. By Route of Administration 11.22.4. By Distribution Channel 11.23. PEST Analysis 11.24. Key Trends 11.24.1. Key Developments 12. Europe Antibacterial Drugs Market Analysis 12.1. Key Findings 12.2. Europe Antibacterial Drugs Market Overview 12.3. Europe Antibacterial Drugs Market Value Share Analysis, By Drug Class 12.4. Europe Antibacterial Drugs Market Forecast, By Drug Class 12.4.1. Penicillins 12.4.2. Cephalosporins 12.4.3. Quinolone 12.4.4. Aminoglycosides 12.4.5. Monobactams 12.4.6. Carbapenems 12.4.7. Macrolides 12.4.8. Other Drug Class 12.5. Europe Antibacterial Drugs Market Value Share Analysis, By Drug Mechanism 12.6. Europe Antibacterial Drugs Market Forecast, By Drug Mechanism 12.6.1. Cell Wall Synthesis inhibitors 12.6.2. Protein Synthesis inhibitors 12.6.3. Nucleic Acid inhibitors 12.6.4. Folic Acid synthesis inhibitors 12.6.5. Mycolic Acid synthesis inhibitors 12.7. Europe Antibacterial Drugs Market Value Share Analysis, By Route of Administration 12.8. Europe Antibacterial Drugs Market Forecast, By Route of Administration 12.8.1. Oral 12.8.2. Topical 12.8.3. Parenteral 12.8.4. Other Route of Administration 12.9. Europe Antibacterial Drugs Market Value Share Analysis, By Distribution Channel 12.10. Europe Antibacterial Drugs Market Forecast, By Distribution Channel 12.10.1. Hospital Pharmacies 12.10.2. Drug Stores & Retail Pharmacies 12.10.3. Online Sales 12.11. Europe Antibacterial Drugs Market Value Share Analysis, by Country 12.12. Europe Antibacterial Drugs Market Forecast, by Country 12.12.1. Germany 12.12.2. U.K. 12.12.3. France 12.12.4. Italy 12.12.5. Spain 12.12.6. Rest of Europe 12.13. Europe Antibacterial Drugs Market Analysis, by Country/ Sub-region 12.14. Germany Antibacterial Drugs Market Forecast, By Drug Class 12.14.1. Penicillins 12.14.2. Cephalosporins 12.14.3. Quinolone 12.14.4. Aminoglycosides 12.14.5. Monobactams 12.14.6. Carbapenems 12.14.7. Macrolides 12.14.8. Other Drug Class 12.15. Germany Antibacterial Drugs Market Forecast, By Drug Mechanism 12.15.1. Cell Wall Synthesis inhibitors 12.15.2. Protein Synthesis inhibitors 12.15.3. Nucleic Acid inhibitors 12.15.4. Folic Acid synthesis inhibitors 12.15.5. Mycolic Acid synthesis inhibitors 12.16. Germany Antibacterial Drugs Market Forecast, By Route of Administration 12.16.1. Oral 12.16.2. Topical 12.16.3. Parenteral 12.16.4. Other Route of Administration 12.17. Germany Antibacterial Drugs Market Forecast, By Distribution Channel 12.17.1. Hospital Pharmacies 12.17.2. Drug Stores & Retail Pharmacies 12.17.3. Online Sales 12.18. U.K. Antibacterial Drugs Market Forecast, By Drug Class 12.18.1. Penicillins 12.18.2. Cephalosporins 12.18.3. Quinolone 12.18.4. Aminoglycosides 12.18.5. Monobactams 12.18.6. Carbapenems 12.18.7. Macrolides 12.18.8. Other Drug Class 12.19. U.K. Antibacterial Drugs Market Forecast, By Drug Mechanism 12.19.1. Cell Wall Synthesis inhibitors 12.19.2. Protein Synthesis inhibitors 12.19.3. Nucleic Acid inhibitors 12.19.4. Folic Acid synthesis inhibitors 12.19.5. Mycolic Acid synthesis inhibitors 12.20. U.K. Antibacterial Drugs Market Forecast, By Route of Administration 12.20.1. Oral 12.20.2. Topical 12.20.3. Parenteral 12.20.4. Other Route of Administration 12.21. U.K. Antibacterial Drugs Market Forecast, By Distribution Channel 12.21.1. Hospital Pharmacies 12.21.2. Drug Stores & Retail Pharmacies 12.21.3. Online Sales 12.22. France Antibacterial Drugs Market Forecast, By Drug Class 12.22.1. Penicillins 12.22.2. Cephalosporins 12.22.3. Quinolone 12.22.4. Aminoglycosides 12.22.5. Monobactams 12.22.6. Carbapenems 12.22.7. Macrolides 12.22.8. Other Drug Class 12.23. France Antibacterial Drugs Market Forecast, By Drug Mechanism 12.23.1. Cell Wall Synthesis inhibitors 12.23.2. Protein Synthesis inhibitors 12.23.3. Nucleic Acid inhibitors 12.23.4. Folic Acid synthesis inhibitors 12.23.5. Mycolic Acid synthesis inhibitors 12.24. France Antibacterial Drugs Market Forecast, By Route of Administration 12.24.1. Oral 12.24.2. Topical 12.24.3. Parenteral 12.24.4. Other Route of Administration 12.25. France Antibacterial Drugs Market Forecast, By Distribution Channel 12.25.1. Hospital Pharmacies 12.25.2. Drug Stores & Retail Pharmacies 12.25.3. Online Sales 12.26. Italy Antibacterial Drugs Market Forecast, By Drug Class 12.26.1. Penicillins 12.26.2. Cephalosporins 12.26.3. Quinolone 12.26.4. Aminoglycosides 12.26.5. Monobactams 12.26.6. Carbapenems 12.26.7. Macrolides 12.26.8. Other Drug Class 12.27. Italy Antibacterial Drugs Market Forecast, By Drug Mechanism 12.27.1. Cell Wall Synthesis inhibitors 12.27.2. Protein Synthesis inhibitors 12.27.3. Nucleic Acid inhibitors 12.27.4. Folic Acid synthesis inhibitors 12.27.5. Mycolic Acid synthesis inhibitors 12.28. Italy Antibacterial Drugs Market Forecast, By Route of Administration 12.28.1. Oral 12.28.2. Topical 12.28.3. Parenteral 12.28.4. Other Route of Administration 12.29. Italy Antibacterial Drugs Market Forecast, By Distribution Channel 12.29.1. Hospital Pharmacies 12.29.2. Drug Stores & Retail Pharmacies 12.29.3. Online Sales 12.30. Spain Antibacterial Drugs Market Forecast, By Drug Class 12.30.1. Penicillins 12.30.2. Cephalosporins 12.30.3. Quinolone 12.30.4. Aminoglycosides 12.30.5. Monobactams 12.30.6. Carbapenems 12.30.7. Macrolides 12.30.8. Other Drug Class 12.31. Spain Antibacterial Drugs Market Forecast, By Drug Mechanism 12.31.1. Cell Wall Synthesis inhibitors 12.31.2. Protein Synthesis inhibitors 12.31.3. Nucleic Acid inhibitors 12.31.4. Folic Acid synthesis inhibitors 12.31.5. Mycolic Acid synthesis inhibitors 12.32. Spain Antibacterial Drugs Market Forecast, By Route of Administration 12.32.1. Oral 12.32.2. Topical 12.32.3. Parenteral 12.32.4. Other Route of Administration 12.33. Spain Antibacterial Drugs Market Forecast, By Distribution Channel 12.33.1. Hospital Pharmacies 12.33.2. Drug Stores & Retail Pharmacies 12.33.3. Online Sales 12.34. Rest of Europe Antibacterial Drugs Market Forecast, By Drug Class 12.34.1. Penicillins 12.34.2. Cephalosporins 12.34.3. Quinolone 12.34.4. Aminoglycosides 12.34.5. Monobactams 12.34.6. Carbapenems 12.34.7. Macrolides 12.34.8. Other Drug Class 12.35. Rest of Europe Antibacterial Drugs Market Forecast, By Drug Mechanism 12.35.1. Cell Wall Synthesis inhibitors 12.35.2. Protein Synthesis inhibitors 12.35.3. Nucleic Acid inhibitors 12.35.4. Folic Acid synthesis inhibitors 12.35.5. Mycolic Acid synthesis inhibitors 12.36. Rest of Europe Antibacterial Drugs Market Forecast, By Route of Administration 12.36.1. Oral 12.36.2. Topical 12.36.3. Parenteral 12.36.4. Other Route of Administration 12.37. Rest Of Europe Antibacterial Drugs Market Forecast, By Distribution Channel 12.37.1. Hospital Pharmacies 12.37.2. Drug Stores & Retail Pharmacies 12.37.3. Online Sales 12.38. Europe Antibacterial Drugs Market Attractiveness Analysis 12.38.1. By Drug Class 12.38.2. By Drug Mechanism 12.38.3. By Route of Administration 12.38.4. By Distribution Channel 12.39. PEST Analysis 12.40. Key Trends 12.40.1. Key Developments 13. Asia Pacific Antibacterial Drugs Market Analysis 13.1. Key Findings 13.2. Asia Pacific Antibacterial Drugs Market Overview 13.3. Asia Pacific Antibacterial Drugs Market Value Share Analysis, By Drug Class 13.4. Asia Pacific Antibacterial Drugs Market Forecast, By Drug Class 13.4.1. Penicillins 13.4.2. Cephalosporins 13.4.3. Quinolone 13.4.4. Aminoglycosides 13.4.5. Monobactams 13.4.6. Carbapenems 13.4.7. Macrolides 13.4.8. Other Drug Class 13.5. Asia Pacific Antibacterial Drugs Market Value Share Analysis, By Drug Mechanism 13.6. Asia Pacific Antibacterial Drugs Market Forecast, By Drug Mechanism 13.6.1. Cell Wall Synthesis inhibitors 13.6.2. Protein Synthesis inhibitors 13.6.3. Nucleic Acid inhibitors 13.6.4. Folic Acid synthesis inhibitors 13.6.5. Mycolic Acid synthesis inhibitors 13.7. Asia Pacific Antibacterial Drugs Market Value Share Analysis, By Route of Administration 13.8. Asia Pacific Antibacterial Drugs Market Forecast, By Route of Administration 13.8.1. Oral 13.8.2. Topical 13.8.3. Parenteral 13.8.4. Other Route of Administration 13.9. Asia Pacific Antibacterial Drugs Market Value Share Analysis, By Distribution Channel 13.10. Asia Pacific Antibacterial Drugs Market Forecast, By Distribution Channel 13.10.1. Hospital Pharmacies 13.10.2. Drug Stores & Retail Pharmacies 13.10.3. Online Sales 13.11. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Country 13.12. Asia Pacific Antibacterial Drugs Market Forecast, by Country 13.12.1. China 13.12.2. India 13.12.3. Japan 13.12.4. ASEAN 13.12.5. Rest of Asia Pacific 13.13. Asia Pacific Antibacterial Drugs Market Analysis, by Country/ Sub-region 13.14. China Antibacterial Drugs Market Forecast, By Drug Class 13.14.1. Penicillins 13.14.2. Cephalosporins 13.14.3. Quinolone 13.14.4. Aminoglycosides 13.14.5. Monobactams 13.14.6. Carbapenems 13.14.7. Macrolides 13.14.8. Other Drug Class 13.15. China Antibacterial Drugs Market Forecast, By Drug Mechanism 13.15.1. Cell Wall Synthesis inhibitors 13.15.2. Protein Synthesis inhibitors 13.15.3. Nucleic Acid inhibitors 13.15.4. Folic Acid synthesis inhibitors 13.15.5. Mycolic Acid synthesis inhibitors 13.16. China Antibacterial Drugs Market Forecast, By Route of Administration 13.16.1. Oral 13.16.2. Topical 13.16.3. Parenteral 13.16.4. Other Route of Administration 13.17. China Antibacterial Drugs Market Forecast, By Distribution Channel 13.17.1. Hospital Pharmacies 13.17.2. Drug Stores & Retail Pharmacies 13.17.3. Online Sales 13.18. India Antibacterial Drugs Market Forecast, By Drug Class 13.18.1. Penicillins 13.18.2. Cephalosporins 13.18.3. Quinolone 13.18.4. Aminoglycosides 13.18.5. Monobactams 13.18.6. Carbapenems 13.18.7. Macrolides 13.18.8. Other Drug Class 13.19. India Antibacterial Drugs Market Forecast, By Drug Mechanism 13.19.1. Cell Wall Synthesis inhibitors 13.19.2. Protein Synthesis inhibitors 13.19.3. Nucleic Acid inhibitors 13.19.4. Folic Acid synthesis inhibitors 13.19.5. Mycolic Acid synthesis inhibitors 13.20. India Antibacterial Drugs Market Forecast, By Route of Administration 13.20.1. Oral 13.20.2. Topical 13.20.3. Parenteral 13.20.4. Other Route of Administration 13.21. India Antibacterial Drugs Market Forecast, By Distribution Channel 13.21.1. Hospital Pharmacies 13.21.2. Drug Stores & Retail Pharmacies 13.21.3. Online Sales 13.22. Japan Antibacterial Drugs Market Forecast, By Drug Class 13.22.1. Penicillins 13.22.2. Cephalosporins 13.22.3. Quinolone 13.22.4. Aminoglycosides 13.22.5. Monobactams 13.22.6. Carbapenems 13.22.7. Macrolides 13.22.8. Other Drug Class 13.23. Japan Antibacterial Drugs Market Forecast, By Drug Mechanism 13.23.1. Cell Wall Synthesis inhibitors 13.23.2. Protein Synthesis inhibitors 13.23.3. Nucleic Acid inhibitors 13.23.4. Folic Acid synthesis inhibitors 13.23.5. Mycolic Acid synthesis inhibitors 13.24. Japan Antibacterial Drugs Market Forecast, By Route of Administration 13.24.1. Oral 13.24.2. Topical 13.24.3. Parenteral 13.24.4. Other Route of Administration 13.25. Japan Antibacterial Drugs Market Forecast, By Distribution Channel 13.25.1. Hospital Pharmacies 13.25.2. Drug Stores & Retail Pharmacies 13.25.3. Online Sales 13.26. ASEAN Antibacterial Drugs Market Forecast, By Drug Class 13.26.1. Penicillins 13.26.2. Cephalosporins 13.26.3. Quinolone 13.26.4. Aminoglycosides 13.26.5. Monobactams 13.26.6. Carbapenems 13.26.7. Macrolides 13.26.8. Other Drug Class 13.27. ASEAN Antibacterial Drugs Market Forecast, By Drug Mechanism 13.27.1. Cell Wall Synthesis inhibitors 13.27.2. Protein Synthesis inhibitors 13.27.3. Nucleic Acid inhibitors 13.27.4. Folic Acid synthesis inhibitors 13.27.5. Mycolic Acid synthesis inhibitors 13.28. ASEAN Antibacterial Drugs Market Forecast, By Route of Administration 13.28.1. Oral 13.28.2. Topical 13.28.3. Parenteral 13.28.4. Other Route of Administration 13.29. ASEAN Antibacterial Drugs Market Forecast, By Distribution Channel 13.29.1. Hospital Pharmacies 13.29.2. Drug Stores & Retail Pharmacies 13.29.3. Online Sales 13.30. Rest of Asia Pacific Antibacterial Drugs Market Forecast, By Drug Class 13.30.1. Penicillins 13.30.2. Cephalosporins 13.30.3. Quinolone 13.30.4. Aminoglycosides 13.30.5. Monobactams 13.30.6. Carbapenems 13.30.7. Macrolides 13.30.8. Other Drug Class 13.31. Rest of Asia Pacific Antibacterial Drugs Market Forecast, By Drug Mechanism 13.31.1. Cell Wall Synthesis inhibitors 13.31.2. Protein Synthesis inhibitors 13.31.3. Nucleic Acid inhibitors 13.31.4. Folic Acid synthesis inhibitors 13.31.5. Mycolic Acid synthesis inhibitors 13.32. Rest of Asia Pacific Antibacterial Drugs Market Forecast, By Route of Administration 13.32.1. Oral 13.32.2. Topical 13.32.3. Parenteral 13.32.4. Other Route of Administration 13.33. Rest of Asia Pacific Antibacterial Drugs Market Forecast, By Distribution Channel 13.33.1. Hospital Pharmacies 13.33.2. Drug Stores & Retail Pharmacies 13.33.3. Online Sales 13.34. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis 13.34.1. By Drug Class 13.34.2. By Drug Mechanism 13.34.3. By Route of Administration 13.34.4. By Distribution Channel 13.35. PEST Analysis 13.36. Key Trends 13.36.1. Key Developments 14. Middle East & Africa Antibacterial Drugs Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Antibacterial Drugs Market Overview 14.3. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, By Drug Class 14.4. Middle East & Africa Antibacterial Drugs Market Forecast, By Drug Class 14.4.1. Penicillins 14.4.2. Cephalosporins 14.4.3. Quinolone 14.4.4. Aminoglycosides 14.4.5. Monobactams 14.4.6. Carbapenems 14.4.7. Macrolides 14.4.8. Other Drug Class 14.5. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, By Drug Mechanism 14.6. Middle East & Africa Antibacterial Drugs Market Forecast, By Drug Mechanism 14.6.1. Cell Wall Synthesis inhibitors 14.6.2. Protein Synthesis inhibitors 14.6.3. Nucleic Acid inhibitors 14.6.4. Folic Acid synthesis inhibitors 14.6.5. Mycolic Acid synthesis inhibitors 14.7. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, By Route of Administration 14.8. Middle East & Africa Antibacterial Drugs Market Forecast, By Route of Administration 14.8.1. Oral 14.8.2. Topical 14.8.3. Parenteral 14.8.4. Other Route of Administration 14.9. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, By Distribution Channel 14.10. Middle East & Africa Antibacterial Drugs Market Forecast, By Distribution Channel 14.10.1. Hospital Pharmacies 14.10.2. Drug Stores & Retail Pharmacies 14.10.3. Online Sales 14.11. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Country 14.12. Middle East & Africa Antibacterial Drugs Market Forecast, by Country 14.12.1. GCC 14.12.2. South Africa 14.12.3. Rest of Middle East & Africa 14.13. Middle East & Africa Antibacterial Drugs Market Analysis, by Country/ Sub-region 14.14. GCC Antibacterial Drugs Market Forecast, By Drug Class 14.14.1. Penicillins 14.14.2. Cephalosporins 14.14.3. Quinolone 14.14.4. Aminoglycosides 14.14.5. Monobactams 14.14.6. Carbapenems 14.14.7. Macrolides 14.14.8. Other Drug Class 14.15. GCC Antibacterial Drugs Market Forecast, By Drug Mechanism 14.15.1. Cell Wall Synthesis inhibitors 14.15.2. Protein Synthesis inhibitors 14.15.3. Nucleic Acid inhibitors 14.15.4. Folic Acid synthesis inhibitors 14.15.5. Mycolic Acid synthesis inhibitors 14.16. GCC Antibacterial Drugs Market Forecast, By Route of Administration 14.16.1. Oral 14.16.2. Topical 14.16.3. Parenteral 14.16.4. Other Route of Administration 14.17. GCC Antibacterial Drugs Market Forecast, By Distribution Channel 14.18. Hospital Pharmacies 14.19. Drug Stores & Retail Pharmacies 14.20. Online Sales 14.21. Others South Africa Antibacterial Drugs Market Forecast, By Drug Class 14.21.1. Penicillins 14.21.2. Cephalosporins 14.21.3. Quinolone 14.21.4. Aminoglycosides 14.21.5. Monobactams 14.21.6. Carbapenems 14.21.7. Macrolides 14.21.8. Other Drug Class 14.22. South Africa Antibacterial Drugs Market Forecast, By Drug Mechanism 14.22.1. Cell Wall Synthesis inhibitors 14.22.2. Protein Synthesis inhibitors 14.22.3. Nucleic Acid inhibitors 14.22.4. Folic Acid synthesis inhibitors 14.22.5. Mycolic Acid synthesis inhibitors 14.23. South Africa Antibacterial Drugs Market Forecast, By Route of Administration 14.23.1. Oral 14.23.2. Topical 14.23.3. Parenteral 14.23.4. Other Route of Administration 14.24. South Africa Antibacterial Drugs Market Forecast, By Distribution Channel 14.24.1. Hospital Pharmacies 14.24.2. Drug Stores & Retail Pharmacies 14.24.3. Online Sales 14.25. Rest of Middle East & Africa Antibacterial Drugs Market Forecast, By Drug Class 14.25.1. Penicillins 14.25.2. Cephalosporins 14.25.3. Quinolone 14.25.4. Aminoglycosides 14.25.5. Monobactams 14.25.6. Carbapenems 14.25.7. Macrolides 14.25.8. Other Drug Class 14.26. Rest of Middle East & Africa Antibacterial Drugs Market Forecast, By Drug Mechanism 14.26.1. Cell Wall Synthesis inhibitors 14.26.2. Protein Synthesis inhibitors 14.26.3. Nucleic Acid inhibitors 14.26.4. Folic Acid synthesis inhibitors 14.26.5. Mycolic Acid synthesis inhibitors 14.27. Rest of Middle East & Africa Antibacterial Drugs Market Forecast, By Route of Administration 14.27.1. Oral 14.27.2. Topical 14.27.3. Parenteral 14.27.4. Other Route of Administration 14.28. Rest of Middle East & Africa Antibacterial Drugs Market Forecast, By Distribution Channel 14.28.1. Hospital Pharmacies 14.28.2. Drug Stores & Retail Pharmacies 14.28.3. Online Sales 14.29. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis 14.29.1. By Drug Class 14.29.2. By Drug Mechanism 14.29.3. By Route of Administration 14.29.4. By Distribution Channel 14.30. PEST Analysis 14.31. Key Trends 14.31.1. Key Developments 15. South America Antibacterial Drugs Market Analysis 15.1. Key Findings 15.2. South America Antibacterial Drugs Market Overview 15.3. South America Antibacterial Drugs Market Value Share Analysis, By Drug Class 15.4. South America Antibacterial Drugs Market Forecast, By Drug Class 15.4.1. Penicillins 15.4.2. Cephalosporins 15.4.3. Quinolone 15.4.4. Aminoglycosides 15.4.5. Monobactams 15.4.6. Carbapenems 15.4.7. Macrolides 15.4.8. Other Drug Class 15.5. South America Antibacterial Drugs Market Value Share Analysis, By Drug Mechanism 15.6. South America Antibacterial Drugs Market Forecast, By Drug Mechanism 15.6.1. Cell Wall Synthesis inhibitors 15.6.2. Protein Synthesis inhibitors 15.6.3. Nucleic Acid inhibitors 15.6.4. Folic Acid synthesis inhibitors 15.6.5. Mycolic Acid synthesis inhibitors 15.7. South America Antibacterial Drugs Market Value Share Analysis, By Route of Administration 15.8. South America Antibacterial Drugs Market Forecast, By Route of Administration 15.8.1. Oral 15.8.2. Topical 15.8.3. Parenteral 15.8.4. Other Route of Administration 15.9. South America Antibacterial Drugs Market Value Share Analysis, By Distribution Channel 15.10. South America Antibacterial Drugs Market Forecast, By Distribution Channel 15.10.1. Hospital Pharmacies 15.10.2. Drug Stores & Retail Pharmacies 15.10.3. Online Sales 15.11. South America Antibacterial Drugs Market Value Share Analysis, by Country 15.12. South America Antibacterial Drugs Market Forecast, by Country 15.12.1. Brazil 15.12.2. Mexico 15.12.3. Rest of South America 15.13. South America Antibacterial Drugs Market Analysis, by Country/ Sub-region 15.14. Brazil Antibacterial Drugs Market Forecast, By Drug Class 15.14.1. Penicillins 15.14.2. Cephalosporins 15.14.3. Quinolone 15.14.4. Aminoglycosides 15.14.5. Monobactams 15.14.6. Carbapenems 15.14.7. Macrolides 15.14.8. Other Drug Class 15.15. Brazil Antibacterial Drugs Market Forecast, By Drug Mechanism 15.15.1. Cell Wall Synthesis inhibitors 15.15.2. Protein Synthesis inhibitors 15.15.3. Nucleic Acid inhibitors 15.15.4. Folic Acid synthesis inhibitors 15.15.5. Mycolic Acid synthesis inhibitors 15.16. Brazil Antibacterial Drugs Market Forecast, By Route of Administration 15.16.1. Oral 15.16.2. Topical 15.16.3. Parenteral 15.16.4. Other Route of Administration 15.17. Brazil Antibacterial Drugs Market Forecast, By Distribution Channel 15.17.1. Hospital Pharmacies 15.17.2. Drug Stores & Retail Pharmacies 15.17.3. Online Sales 15.18. Mexico Antibacterial Drugs Market Forecast, By Drug Class 15.18.1. Penicillins 15.18.2. Cephalosporins 15.18.3. Quinolone 15.18.4. Aminoglycosides 15.18.5. Monobactams 15.18.6. Carbapenems 15.18.7. Macrolides 15.18.8. Other Drug Class 15.19. Mexico Antibacterial Drugs Market Forecast, By Drug Mechanism 15.19.1. Cell Wall Synthesis inhibitors 15.19.2. Protein Synthesis inhibitors 15.19.3. Nucleic Acid inhibitors 15.19.4. Folic Acid synthesis inhibitors 15.19.5. Mycolic Acid synthesis inhibitors 15.20. Mexico Antibacterial Drugs Market Forecast, By Route of Administration 15.20.1. Oral 15.20.2. Topical 15.20.3. Parenteral 15.20.4. Other Route of Administration 15.21. Mexico Antibacterial Drugs Market Forecast, By Distribution Channel 15.21.1. Hospital Pharmacies 15.21.2. Drug Stores & Retail Pharmacies 15.21.3. Online Sales 15.22. Rest of South America Antibacterial Drugs Market Forecast, By Drug Class 15.22.1. Penicillins 15.22.2. Cephalosporins 15.22.3. Quinolone 15.22.4. Aminoglycosides 15.22.5. Monobactams 15.22.6. Carbapenems 15.22.7. Macrolides 15.22.8. Other Drug Class 15.23. Rest of South America Antibacterial Drugs Market Forecast, By Drug Mechanism 15.23.1. Cell Wall Synthesis inhibitors 15.23.2. Protein Synthesis inhibitors 15.23.3. Nucleic Acid inhibitors 15.23.4. Folic Acid synthesis inhibitors 15.23.5. Mycolic Acid synthesis inhibitors 15.24. Rest of South America Antibacterial Drugs Market Forecast, By Route of Administration 15.24.1. Oral 15.24.2. Topical 15.24.3. Parenteral 15.24.4. Other Route of Administration 15.25. Rest of South America Antibacterial Drugs Market Forecast, By Distribution Channel 15.25.1. Hospital Pharmacies 15.25.2. Drug Stores & Retail Pharmacies 15.25.3. Online Sales 15.26. South America Antibacterial Drugs Market Attractiveness Analysis 15.26.1. By Drug Class 15.26.2. By Drug Mechanism 15.26.3. By Route of Administration 15.26.4. By Distribution Channel 15.27. PEST Analysis 15.28. Key Trends 15.28.1. Key Developments 16. Company Landscape 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.3. Competitive Benchmarking of Company and Services 16.4. Company Profiles: Key Players 16.4.1. Allergen Plc. 16.4.1.1. Company Overview 16.4.1.2. Financial Overview 16.4.1.3. Business Strategy 16.4.1.4. Recent Developments 16.4.1.5. Development Footprint 16.4.2. Pfizer, Inc. 16.4.3. Merck & Co., Inc. 16.4.4. GlaxoSmithKline plc. 16.4.5. Novartis AG 16.4.6. Eli Lilly & Company 16.4.7. Johnson & Johnson 16.4.8. Sanofi 16.4.9. AstraZeneca plc. 16.4.10. Bayer AG 16.4.11. Abbott Laboratories 16.4.12. Daiichi Sankyo Company 16.4.13. Takeda Pharmaceutical Company Ltd 16.4.14. Bristol Myers Squibb Company 17. Primary Key Insights

About This Report

Report ID 23877
Category Healthcare
Published Date Jan 2019
Updated Date Nov 2020
Contact Us